<DOC>
	<DOCNO>NCT00004848</DOCNO>
	<brief_summary>This protocol represent continuation series prospective study define incidence etiology transfusion-associated hepatitis ( TAH ) examine impact TAH various modification selection blood donor . The primary goal study determine TAH incidence institution variety interventive measure exclude hepatitis AIDS virus carrier : include surrogate assay ( ALT , anti-HBc ) , specific assay hepatitis C virus ( HCV ) , specific assay human immunodeficiency virus ( HIV ) intensify donor question high-risk behavior pattern . There high probability exclusion donor high risk AIDS transmission also exclude donor high risk hepatitis transmission . Incidence data obtain study enhance simultaneous follow-up control population undergo identical surgical procedure , receive blood autologous blood . This control population , make possible recent dramatic increase amount autologous blood utilized , allow clear distinction transfusion-associated hepatitis due nosocomial transmission background cause hepatocellular inflammation cardiac surgery patient .</brief_summary>
	<brief_title>A Controlled Prospective Study Transfusion-Associated Hepatitis</brief_title>
	<detailed_description>This protocol represent continuation series prospective study define incidence etiology transfusion-associated hepatitis ( TAH ) examine impact TAH various modification selection blood donor . The primary goal study determine TAH incidence institution variety interventive measure exclude hepatitis AIDS virus carrier : include surrogate assay ( ALT , anti-HBc ) , specific assay hepatitis C virus ( HCV ) , specific assay human immunodeficiency virus ( HIV ) intensify donor question high-risk behavior pattern . There high probability exclusion donor high risk AIDS transmission also exclude donor high risk hepatitis transmission . Incidence data obtain study enhance simultaneous follow-up control population undergo identical surgical procedure , receive blood autologous blood . This control population , make possible recent dramatic increase amount autologous blood utilized , allow clear distinction transfusion-associated hepatitis due nosocomial transmission background cause hepatocellular inflammation cardiac surgery patient .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<criteria>Consecutive patient undergo openheart surgery Georgetown University Fairfax Hospital admit study : They 18 year age old ; They provide informed consent ; They reside United States available least six month follow . Patients know hepatitis C hepatitis B virus carrier without evidence chronic hepatitis exclude . Persons history prior hepatitis exclude , analyzed separate cohort . Patients close exposure ( household sexual contact ) hepatitis precede six month exclude . Patients elevate preoperative alanine aminotransferase ( ALT ) exclude . An aspartate aminotransferase ( AST ) 45 75 IU per L serve cause exclusion correspond ALT normal least two occasion . A preoperative AST great 75 IU/L serve exclude patient study independent ALT . Patients blood transfusion six month precede surgery exclude . Patients also retrospectively exclude receive blood one month surgery . The six month followup period time date last transfusion . Patients alcoholism know liver active biliary tract disease time entrance study exclude . Patients inadequate vein obtain required sample exclude .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 1999</verification_date>
	<keyword>AIDS</keyword>
	<keyword>Autologous Blood</keyword>
	<keyword>Cardiac Surgery</keyword>
	<keyword>HIV</keyword>
	<keyword>Hepatocellular Inflammation</keyword>
	<keyword>Liver Biopsy</keyword>
	<keyword>Long Term Sera Storage</keyword>
	<keyword>Non-A Hepatitis</keyword>
	<keyword>Non-B Hepatitis</keyword>
</DOC>